Richard D Carvajal (R D Carvajal, Richard Carvajal)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Low Density Lipoprotein

Basal Cell Carcinoma

Top Venues

Cancer research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Prabhjot S Mundi, Filemon Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R Rainey, Kristina Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, Charles Karan, Michael V Ortiz, Eugene F Douglass, Melissa K Accordino, Suzanne Mistretta, Frances L Brogan, Jeffrey N Bruce, Cristina I Caescu, Richard D Carvajal, Katherine D Crew, Guarionex Decastro, Mark Heaney, Brian S Henick, Dawn L Hershman, June Y Hou, Fabio M Iwamoto, Joseph G Jurcic, Ravi P Kiran, Michael D Kluger, Teri Kreisl, Nicole Lamanna, Andrew B Lassman, Emerson A Lim, Gulam A Manji, Guy M McKhann, James M McKiernan, Alfred I Neugut, Kenneth P Olive, Todd Rosenblat, Gary K Schwartz, Catherine A Shu, Michael B Sisti, Ana I Tergas, Reena M Vattakalam, Mary R Welch, Sven Wenske, Jason D Wright, Peter Canoll, Hanina Hibshoosh, Kevin M Kalinsky, Mahalaxmi Aburi, Peter A Sims, Mariano J Alvarez, Andrew L Kung, Andrea Califano
A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies. Cancer discovery (2023)
Fatima Fayyaz, Richard D Carvajal, Craig E Devoe
Diversifying Eligibility to Enhance Real-World Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ha-Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie J Shawber, Richard D Carvajal, Gavin Thurston, Joon-Yong An, Amanda W Lund, Hee Won Yang, Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer research (2023)
Ha-Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie J Shawber, Richard D Carvajal, Gavin Thurston, Joon-Yong An, Amanda W Lund, Hee Won Yang, Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer research (2023)
Ha-Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie J Shawber, Richard D Carvajal, Gavin Thurston, Joon-Yong An, Amanda W Lund, Hee Won Yang, Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer research (2023)
Ha-Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie J Shawber, Richard D Carvajal, Gavin Thurston, Joon-Yong An, Amanda W Lund, Hee Won Yang, Minah Kim
Angiopoietin-2-dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma. Cancer research (2023)
Richard D Carvajal, Paul D Nathan, Joseph J Sacco, Marlana Orloff, Leonel F Hernandez-Aya, Jessica Yang, Jason John Luke, Marcus O Butler, Sarah Stanhope, Laura Collins, Cheryl McAlpine, Chris Holland, Shaad E Abdullah, Takami Sato
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Jonathan Wade Goldman, Sarina A Piha-Paul, Brendan D Curti, Katrina S Pedersen, Todd M Bauer, Stefanie L Groenland, Richard D Carvajal, Vaishali Chhaya, Gray Kirby, Kelly McGlinchey, Scott A Hammond, Katie Streicher, Danielle M Townsley, Young Kwang Chae, Jens Voortman, Aurélien Marabelle, John D Powderly
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Siqing Fu, Shuyang Yao, Yuan Yuan, Rebecca Ann Previs, Anthony D Elias, Richard D Carvajal, Thomas J George, Ying Yuan, Lihou Yu, Shannon Neville Westin, Yan Xing, Ecaterina E Ileana Dumbrava, Daniel D Karp, Sarina A Piha-Paul, Apostolia-Maria Tsimberidou, Jordi Rodon Ahnert, Naoko Takebe, Karen H Lu, Khandan Keyomarsi, Funda Meric-Bernstam
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Alexander Z Wei, Ashray B Maniar, Richard D Carvajal
New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma. Cancer gene therapy (2022)
Alexander N Shoushtari, Shaheer Khan, Kimberly Komatsubara, Lynn Feun, Nicolas Acquavella, Shahnaz Singh-Kandah, Tiffany Negri, Alexandra Nesson, Kelly Abbate, Serge Cremers, Elgilda Musi, Grazia Ambrosini, Shing Lee, Gary K Schwartz, Richard D Carvajal
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 13 (21) (2021)
J Yang, S M Lagana, Y M Saenger, Richard D Carvajal
Dual checkpoint inhibitor-associated eosinophilic enteritis. Journal for immunotherapy of cancer 7 (1) (2019)